Freedom Investment Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
FAM
DGI
CPH
Freedom Investment Management's CLB Position: Q1 2022 in Review
Freedom Investment Management sold out of Core Laboratories (CLB) in Q1 2022, closing a stake of 74,302 shares — an estimated $1.66M sold.
Freedom Investment Management first reported a position in CLB in Q4 2016 and held it in 15 quarters. The position peaked at $2.68M in Q2 2021. 196 funds tracked by Wall St. Rank hold CLB as of Q1 2022.
- Freedom Investment Management reported no remaining Core Laboratories position as of Q1 2022 after selling out during the quarter.
- Freedom Investment Management sold 74,302 Core Laboratories shares in Q1 2022, an estimated $1.66M.
- Freedom Investment Management first reported a position in Core Laboratories in Q4 2016 and held it in 15 quarters.
- Freedom Investment Management's Core Laboratories position peaked at $2.68M in Q2 2021.
- 196 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2022.
Based on Freedom Investment Management's 13F filing for Q1 2022, filed 16 May 2022.